Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73901 - 73925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	HTT	3064	downregulated	Silver results in decreased expression of HTT mRNA	4p16.3	A24216
Silver	Approved Investigational	IFNA1	3439	downregulated	Silver results in decreased expression of IFNA1 mRNA	9p21.3	A24217
Silver	Approved Investigational	IFNB1	3456	upregulated	Silver analog results in increased expression of IFNB1 mRNA	9p21.3	A24225
Silver	Approved Investigational	IFNGR1	3459	upregulated	Silver results in increased expression of IFNGR1 mRNA	6q23.3	A24217
Silver	Approved Investigational	IL10	3586	upregulated	Silver analog results in increased expression of IL10 mRNA	1q32.1	A24225
Silver	Approved Investigational	IL11	3589	upregulated	Silver results in increased expression of IL11 mRNA	19q13.42	A24216
Silver	Approved Investigational	IL1R1	3554	downregulated	Silver analog results in decreased expression of IL1R1 mRNA	2q11.2-q12.1	A24225
Silver	Approved Investigational	IL1R1	3554	upregulated	Silver analog results in increased expression of IL1R1 mRNA	2q11.2-q12.1	A24224
Silver	Approved Investigational	IL1R1	3554	downregulated	Silver results in decreased expression of IL1R1 mRNA	2q11.2-q12.1	A24217
Silver	Approved Investigational	IL1RAP	3556	upregulated	Silver results in increased expression of IL1RAP mRNA	3q28	A24217
Silver	Approved Investigational	IL1RL2	8808	downregulated	Silver results in decreased expression of IL1RL2 mRNA	2q12.1	A24217
Silver	Approved Investigational	IL6	3569	upregulated	Silver results in increased expression of IL6 mRNA	7p15.3	A24217
Silver	Approved Investigational	IRAK1	3654	upregulated	Silver results in increased expression of IRAK1 mRNA	Xq28	A24217
Silver	Approved Investigational	IRF1	3659	downregulated	Silver results in decreased expression of IRF1 mRNA	5q31.1	A24217
Silver	Approved Investigational	IRS2	8660	upregulated	Silver results in increased expression of IRS2 mRNA	13q34	A24216
Silver	Approved Investigational	ISL2	64843	upregulated	Silver results in increased expression of ISL2 mRNA	15q24.3	A24216
Silver	Approved Investigational	JUN	3725	upregulated	Silver analog results in increased expression of JUN mRNA	1p32.1	A24225
Silver	Approved Investigational	KCNJ8	3764	downregulated	Silver results in decreased expression of KCNJ8 mRNA	12p12.1	A24216
Silver	Approved Investigational	KRT40	125115	downregulated	Silver results in decreased expression of KRT40 mRNA	17q21.2	A24216
Silver	Approved Investigational	LINC00304	283860	upregulated	Silver results in increased expression of LINC00304 mRNA	16q24.3	A24216
Silver	Approved Investigational	LY96	23643	upregulated	Silver results in increased expression of LY96 mRNA	8q21.11	A24217
Silver	Approved Investigational	MAP3K1	4214	downregulated	Silver analog results in decreased expression of MAP3K1 mRNA	5q11.2	A24225
Silver	Approved Investigational	MFAP4	4239	upregulated	Silver analog results in increased expression of MFAP4 mRNA	17p11.2	A24215
Silver	Approved Investigational	MIF	4282	upregulated	Silver results in increased expression of MIF mRNA	22q11.23	A24217
Silver	Approved Investigational	MIR106A	406899	downregulated	Silver analog results in decreased expression of MIR106A mRNA	Xq26.2	A24215

Displaying entries 73901 - 73925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability